世界の新型コロナウイルス感染症用医薬品API市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global COVID-19 Drug API Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5680 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、新型コロナウイルス感染症用医薬品APIの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヒドロキシクロロキン、クロロキンリン酸塩、その他）、用途別市場規模（錠剤、注射）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・新型コロナウイルス感染症用医薬品APIの市場動向 ・企業の競争状況、市場シェア ・新型コロナウイルス感染症用医薬品APIの種類別市場規模と予測2016-2027（ヒドロキシクロロキン、クロロキンリン酸塩、その他） ・新型コロナウイルス感染症用医薬品APIの用途別市場規模と予測2016-2027（錠剤、注射） ・新型コロナウイルス感染症用医薬品APIの北米市場規模2016-2027（アメリカ、カナダ） ・新型コロナウイルス感染症用医薬品APIの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・新型コロナウイルス感染症用医薬品APIのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・新型コロナウイルス感染症用医薬品APIの中南米市場規模2016-2027（メキシコ、ブラジル） ・新型コロナウイルス感染症用医薬品APIの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Shanghai Zhongxi Sunve Pharma Co., Ltd.、Cinkate、Fuan Pharmaceutical Group、Wuhan Wuyao Pharmaceutical Co., Ltd、Shenhua Pharmaceutical Co., Ltd、Chongqing Kangle Pharmaceutical Co., Ltd.） ・結論

Market Analysis and Insights: Global COVID-19 Drug API Market
The global COVID-19 Drug API market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global COVID-19 Drug API market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global COVID-19 Drug API market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global COVID-19 Drug API market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global COVID-19 Drug API market.

Global COVID-19 Drug API Scope and Market Size
COVID-19 Drug API market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global COVID-19 Drug API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Hydroxychloroquine
Chloroquine Phosphate
Others

Segment by Application
Tablet
Injection

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Shanghai Zhongxi Sunve Pharma Co., Ltd.
Cinkate
Fuan Pharmaceutical Group
Wuhan Wuyao Pharmaceutical Co., Ltd
Shenhua Pharmaceutical Co., Ltd
Chongqing Kangle Pharmaceutical Co., Ltd.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Drug API Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hydroxychloroquine
1.2.3 Chloroquine Phosphate
1.2.4 Others
1.3 Market by Application
1.3.1 Global COVID-19 Drug API Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Tablet
1.3.3 Injection
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global COVID-19 Drug API Market Perspective (2016-2027)
2.2 COVID-19 Drug API Growth Trends by Regions
2.2.1 COVID-19 Drug API Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 COVID-19 Drug API Historic Market Share by Regions (2016-2021)
2.2.3 COVID-19 Drug API Forecasted Market Size by Regions (2022-2027)
2.3 COVID-19 Drug API Industry Dynamic
2.3.1 COVID-19 Drug API Market Trends
2.3.2 COVID-19 Drug API Market Drivers
2.3.3 COVID-19 Drug API Market Challenges
2.3.4 COVID-19 Drug API Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top COVID-19 Drug API Players by Revenue
3.1.1 Global Top COVID-19 Drug API Players by Revenue (2016-2021)
3.1.2 Global COVID-19 Drug API Revenue Market Share by Players (2016-2021)
3.2 Global COVID-19 Drug API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by COVID-19 Drug API Revenue
3.4 Global COVID-19 Drug API Market Concentration Ratio
3.4.1 Global COVID-19 Drug API Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Drug API Revenue in 2020
3.5 COVID-19 Drug API Key Players Head office and Area Served
3.6 Key Players COVID-19 Drug API Product Solution and Service
3.7 Date of Enter into COVID-19 Drug API Market
3.8 Mergers & Acquisitions, Expansion Plans

4 COVID-19 Drug API Breakdown Data by Type
4.1 Global COVID-19 Drug API Historic Market Size by Type (2016-2021)
4.2 Global COVID-19 Drug API Forecasted Market Size by Type (2022-2027)

5 COVID-19 Drug API Breakdown Data by Application
5.1 Global COVID-19 Drug API Historic Market Size by Application (2016-2021)
5.2 Global COVID-19 Drug API Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America COVID-19 Drug API Market Size (2016-2027)
6.2 North America COVID-19 Drug API Market Size by Type
6.2.1 North America COVID-19 Drug API Market Size by Type (2016-2021)
6.2.2 North America COVID-19 Drug API Market Size by Type (2022-2027)
6.2.3 North America COVID-19 Drug API Market Size by Type (2016-2027)
6.3 North America COVID-19 Drug API Market Size by Application
6.3.1 North America COVID-19 Drug API Market Size by Application (2016-2021)
6.3.2 North America COVID-19 Drug API Market Size by Application (2022-2027)
6.3.3 North America COVID-19 Drug API Market Size by Application (2016-2027)
6.4 North America COVID-19 Drug API Market Size by Country
6.4.1 North America COVID-19 Drug API Market Size by Country (2016-2021)
6.4.2 North America COVID-19 Drug API Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe COVID-19 Drug API Market Size (2016-2027)
7.2 Europe COVID-19 Drug API Market Size by Type
7.2.1 Europe COVID-19 Drug API Market Size by Type (2016-2021)
7.2.2 Europe COVID-19 Drug API Market Size by Type (2022-2027)
7.2.3 Europe COVID-19 Drug API Market Size by Type (2016-2027)
7.3 Europe COVID-19 Drug API Market Size by Application
7.3.1 Europe COVID-19 Drug API Market Size by Application (2016-2021)
7.3.2 Europe COVID-19 Drug API Market Size by Application (2022-2027)
7.3.3 Europe COVID-19 Drug API Market Size by Application (2016-2027)
7.4 Europe COVID-19 Drug API Market Size by Country
7.4.1 Europe COVID-19 Drug API Market Size by Country (2016-2021)
7.4.2 Europe COVID-19 Drug API Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific COVID-19 Drug API Market Size (2016-2027)
8.2 Asia-Pacific COVID-19 Drug API Market Size by Type
8.2.1 Asia-Pacific COVID-19 Drug API Market Size by Type (2016-2021)
8.2.2 Asia-Pacific COVID-19 Drug API Market Size by Type (2022-2027)
8.2.3 Asia-Pacific COVID-19 Drug API Market Size by Type (2016-2027)
8.3 Asia-Pacific COVID-19 Drug API Market Size by Application
8.3.1 Asia-Pacific COVID-19 Drug API Market Size by Application (2016-2021)
8.3.2 Asia-Pacific COVID-19 Drug API Market Size by Application (2022-2027)
8.3.3 Asia-Pacific COVID-19 Drug API Market Size by Application (2016-2027)
8.4 Asia-Pacific COVID-19 Drug API Market Size by Region
8.4.1 Asia-Pacific COVID-19 Drug API Market Size by Region (2016-2021)
8.4.2 Asia-Pacific COVID-19 Drug API Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America COVID-19 Drug API Market Size (2016-2027)
9.2 Latin America COVID-19 Drug API Market Size by Type
9.2.1 Latin America COVID-19 Drug API Market Size by Type (2016-2021)
9.2.2 Latin America COVID-19 Drug API Market Size by Type (2022-2027)
9.2.3 Latin America COVID-19 Drug API Market Size by Type (2016-2027)
9.3 Latin America COVID-19 Drug API Market Size by Application
9.3.1 Latin America COVID-19 Drug API Market Size by Application (2016-2021)
9.3.2 Latin America COVID-19 Drug API Market Size by Application (2022-2027)
9.3.3 Latin America COVID-19 Drug API Market Size by Application (2016-2027)
9.4 Latin America COVID-19 Drug API Market Size by Country
9.4.1 Latin America COVID-19 Drug API Market Size by Country (2016-2021)
9.4.2 Latin America COVID-19 Drug API Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa COVID-19 Drug API Market Size (2016-2027)
10.2 Middle East & Africa COVID-19 Drug API Market Size by Type
10.2.1 Middle East & Africa COVID-19 Drug API Market Size by Type (2016-2021)
10.2.2 Middle East & Africa COVID-19 Drug API Market Size by Type (2022-2027)
10.2.3 Middle East & Africa COVID-19 Drug API Market Size by Type (2016-2027)
10.3 Middle East & Africa COVID-19 Drug API Market Size by Application
10.3.1 Middle East & Africa COVID-19 Drug API Market Size by Application (2016-2021)
10.3.2 Middle East & Africa COVID-19 Drug API Market Size by Application (2022-2027)
10.3.3 Middle East & Africa COVID-19 Drug API Market Size by Application (2016-2027)
10.4 Middle East & Africa COVID-19 Drug API Market Size by Country
10.4.1 Middle East & Africa COVID-19 Drug API Market Size by Country (2016-2021)
10.4.2 Middle East & Africa COVID-19 Drug API Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Shanghai Zhongxi Sunve Pharma Co., Ltd.
11.1.1 Shanghai Zhongxi Sunve Pharma Co., Ltd. Company Details
11.1.2 Shanghai Zhongxi Sunve Pharma Co., Ltd. Business Overview
11.1.3 Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Introduction
11.1.4 Shanghai Zhongxi Sunve Pharma Co., Ltd. Revenue in COVID-19 Drug API Business (2016-2021)
11.1.5 Shanghai Zhongxi Sunve Pharma Co., Ltd. Recent Development
11.2 Cinkate
11.2.1 Cinkate Company Details
11.2.2 Cinkate Business Overview
11.2.3 Cinkate COVID-19 Drug API Introduction
11.2.4 Cinkate Revenue in COVID-19 Drug API Business (2016-2021)
11.2.5 Cinkate Recent Development
11.3 Fuan Pharmaceutical Group
11.3.1 Fuan Pharmaceutical Group Company Details
11.3.2 Fuan Pharmaceutical Group Business Overview
11.3.3 Fuan Pharmaceutical Group COVID-19 Drug API Introduction
11.3.4 Fuan Pharmaceutical Group Revenue in COVID-19 Drug API Business (2016-2021)
11.3.5 Fuan Pharmaceutical Group Recent Development
11.4 Wuhan Wuyao Pharmaceutical Co., Ltd
11.4.1 Wuhan Wuyao Pharmaceutical Co., Ltd Company Details
11.4.2 Wuhan Wuyao Pharmaceutical Co., Ltd Business Overview
11.4.3 Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Introduction
11.4.4 Wuhan Wuyao Pharmaceutical Co., Ltd Revenue in COVID-19 Drug API Business (2016-2021)
11.4.5 Wuhan Wuyao Pharmaceutical Co., Ltd Recent Development
11.5 Shenhua Pharmaceutical Co., Ltd
11.5.1 Shenhua Pharmaceutical Co., Ltd Company Details
11.5.2 Shenhua Pharmaceutical Co., Ltd Business Overview
11.5.3 Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Introduction
11.5.4 Shenhua Pharmaceutical Co., Ltd Revenue in COVID-19 Drug API Business (2016-2021)
11.5.5 Shenhua Pharmaceutical Co., Ltd Recent Development
11.6 Chongqing Kangle Pharmaceutical Co., Ltd.
11.6.1 Chongqing Kangle Pharmaceutical Co., Ltd. Company Details
11.6.2 Chongqing Kangle Pharmaceutical Co., Ltd. Business Overview
11.6.3 Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Introduction
11.6.4 Chongqing Kangle Pharmaceutical Co., Ltd. Revenue in COVID-19 Drug API Business (2016-2021)
11.6.5 Chongqing Kangle Pharmaceutical Co., Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global COVID-19 Drug API Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hydroxychloroquine
Table 3. Key Players of Chloroquine Phosphate
Table 4. Key Players of Others
Table 5. Global COVID-19 Drug API Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global COVID-19 Drug API Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global COVID-19 Drug API Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global COVID-19 Drug API Market Share by Regions (2016-2021)
Table 9. Global COVID-19 Drug API Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global COVID-19 Drug API Market Share by Regions (2022-2027)
Table 11. COVID-19 Drug API Market Trends
Table 12. COVID-19 Drug API Market Drivers
Table 13. COVID-19 Drug API Market Challenges
Table 14. COVID-19 Drug API Market Restraints
Table 15. Global COVID-19 Drug API Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global COVID-19 Drug API Market Share by Players (2016-2021)
Table 17. Global Top COVID-19 Drug API Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COVID-19 Drug API as of 2020)
Table 18. Ranking of Global Top COVID-19 Drug API Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by COVID-19 Drug API Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players COVID-19 Drug API Product Solution and Service
Table 22. Date of Enter into COVID-19 Drug API Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global COVID-19 Drug API Market Size by Type (2016-2021) (US$ Million)
Table 25. Global COVID-19 Drug API Revenue Market Share by Type (2016-2021)
Table 26. Global COVID-19 Drug API Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global COVID-19 Drug API Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global COVID-19 Drug API Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global COVID-19 Drug API Revenue Market Share by Application (2016-2021)
Table 30. Global COVID-19 Drug API Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global COVID-19 Drug API Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America COVID-19 Drug API Market Size by Type (2016-2021) (US$ Million)
Table 33. North America COVID-19 Drug API Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America COVID-19 Drug API Market Size by Application (2016-2021) (US$ Million)
Table 35. North America COVID-19 Drug API Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America COVID-19 Drug API Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America COVID-19 Drug API Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe COVID-19 Drug API Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe COVID-19 Drug API Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe COVID-19 Drug API Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe COVID-19 Drug API Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe COVID-19 Drug API Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe COVID-19 Drug API Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific COVID-19 Drug API Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific COVID-19 Drug API Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific COVID-19 Drug API Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific COVID-19 Drug API Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific COVID-19 Drug API Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific COVID-19 Drug API Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America COVID-19 Drug API Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America COVID-19 Drug API Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America COVID-19 Drug API Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America COVID-19 Drug API Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America COVID-19 Drug API Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America COVID-19 Drug API Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa COVID-19 Drug API Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa COVID-19 Drug API Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa COVID-19 Drug API Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa COVID-19 Drug API Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa COVID-19 Drug API Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa COVID-19 Drug API Market Size by Country (2022-2027) & (US$ Million)
Table 62. Shanghai Zhongxi Sunve Pharma Co., Ltd. Company Details
Table 63. Shanghai Zhongxi Sunve Pharma Co., Ltd. Business Overview
Table 64. Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Product
Table 65. Shanghai Zhongxi Sunve Pharma Co., Ltd. Revenue in COVID-19 Drug API Business (2016-2021) & (US$ Million)
Table 66. Shanghai Zhongxi Sunve Pharma Co., Ltd. Recent Development
Table 67. Cinkate Company Details
Table 68. Cinkate Business Overview
Table 69. Cinkate COVID-19 Drug API Product
Table 70. Cinkate Revenue in COVID-19 Drug API Business (2016-2021) & (US$ Million)
Table 71. Cinkate Recent Development
Table 72. Fuan Pharmaceutical Group Company Details
Table 73. Fuan Pharmaceutical Group Business Overview
Table 74. Fuan Pharmaceutical Group COVID-19 Drug API Product
Table 75. Fuan Pharmaceutical Group Revenue in COVID-19 Drug API Business (2016-2021) & (US$ Million)
Table 76. Fuan Pharmaceutical Group Recent Development
Table 77. Wuhan Wuyao Pharmaceutical Co., Ltd Company Details
Table 78. Wuhan Wuyao Pharmaceutical Co., Ltd Business Overview
Table 79. Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Product
Table 80. Wuhan Wuyao Pharmaceutical Co., Ltd Revenue in COVID-19 Drug API Business (2016-2021) & (US$ Million)
Table 81. Wuhan Wuyao Pharmaceutical Co., Ltd Recent Development
Table 82. Shenhua Pharmaceutical Co., Ltd Company Details
Table 83. Shenhua Pharmaceutical Co., Ltd Business Overview
Table 84. Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Product
Table 85. Shenhua Pharmaceutical Co., Ltd Revenue in COVID-19 Drug API Business (2016-2021) & (US$ Million)
Table 86. Shenhua Pharmaceutical Co., Ltd Recent Development
Table 87. Chongqing Kangle Pharmaceutical Co., Ltd. Company Details
Table 88. Chongqing Kangle Pharmaceutical Co., Ltd. Business Overview
Table 89. Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Product
Table 90. Chongqing Kangle Pharmaceutical Co., Ltd. Revenue in COVID-19 Drug API Business (2016-2021) & (US$ Million)
Table 91. Chongqing Kangle Pharmaceutical Co., Ltd. Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COVID-19 Drug API Market Share by Type: 2020 VS 2027
Figure 2. Hydroxychloroquine Features
Figure 3. Chloroquine Phosphate Features
Figure 4. Others Features
Figure 5. Global COVID-19 Drug API Market Share by Application: 2020 VS 2027
Figure 6. Tablet Case Studies
Figure 7. Injection Case Studies
Figure 8. COVID-19 Drug API Report Years Considered
Figure 9. Global COVID-19 Drug API Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global COVID-19 Drug API Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global COVID-19 Drug API Market Share by Regions: 2020 VS 2027
Figure 12. Global COVID-19 Drug API Market Share by Regions (2022-2027)
Figure 13. Global COVID-19 Drug API Market Share by Players in 2020
Figure 14. Global Top COVID-19 Drug API Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COVID-19 Drug API as of 2020
Figure 15. The Top 10 and 5 Players Market Share by COVID-19 Drug API Revenue in 2020
Figure 16. Global COVID-19 Drug API Revenue Market Share by Type (2016-2021)
Figure 17. Global COVID-19 Drug API Revenue Market Share by Type (2022-2027)
Figure 18. North America COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America COVID-19 Drug API Market Share by Type (2016-2027)
Figure 20. North America COVID-19 Drug API Market Share by Application (2016-2027)
Figure 21. North America COVID-19 Drug API Market Share by Country (2016-2027)
Figure 22. United States COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe COVID-19 Drug API Market Share by Type (2016-2027)
Figure 26. Europe COVID-19 Drug API Market Share by Application (2016-2027)
Figure 27. Europe COVID-19 Drug API Market Share by Country (2016-2027)
Figure 28. Germany COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific COVID-19 Drug API Market Share by Type (2016-2027)
Figure 36. Asia-Pacific COVID-19 Drug API Market Share by Application (2016-2027)
Figure 37. Asia-Pacific COVID-19 Drug API Market Share by Region (2016-2027)
Figure 38. China COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America COVID-19 Drug API Market Share by Type (2016-2027)
Figure 46. Latin America COVID-19 Drug API Market Share by Application (2016-2027)
Figure 47. Latin America COVID-19 Drug API Market Share by Country (2016-2027)
Figure 48. Mexico COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa COVID-19 Drug API Market Share by Type (2016-2027)
Figure 52. Middle East & Africa COVID-19 Drug API Market Share by Application (2016-2027)
Figure 53. Middle East & Africa COVID-19 Drug API Market Share by Country (2016-2027)
Figure 54. Turkey COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE COVID-19 Drug API Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Shanghai Zhongxi Sunve Pharma Co., Ltd. Revenue Growth Rate in COVID-19 Drug API Business (2016-2021)
Figure 58. Cinkate Revenue Growth Rate in COVID-19 Drug API Business (2016-2021)
Figure 59. Fuan Pharmaceutical Group Revenue Growth Rate in COVID-19 Drug API Business (2016-2021)
Figure 60. Wuhan Wuyao Pharmaceutical Co., Ltd Revenue Growth Rate in COVID-19 Drug API Business (2016-2021)
Figure 61. Shenhua Pharmaceutical Co., Ltd Revenue Growth Rate in COVID-19 Drug API Business (2016-2021)
Figure 62. Chongqing Kangle Pharmaceutical Co., Ltd. Revenue Growth Rate in COVID-19 Drug API Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

---